April 16, 2024 | Client News
MELBOURNE, Australia, April 16, 2024–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s “composition of proenzymes for cancer treatment,” patent was received from the European Patent Office. The […]
April 16, 2024 | Client News
Nashville, TN, April 16, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, and American Rebel Beer (americanrebelbeer.com), announced its financial results for the year ended December 31, 2023. Investors are encouraged to read […]
April 16, 2024 | Client News, NASDAQ: LASE
ORLANDO, Fla., April 16, 2024–(BUSINESS WIRE)–Laser Photonics Corporation (LPC) (NASDAQ: LASE), a leading global developer of industrial laser systems for cleaning and other material processing applications, announced today that it is attending this year’s NCMS Commercial Technologies for Maintenance Activities (CTMA) Partners Meeting. Set to take place from May 7 to May 9 in Providence, Rhode Island, the […]
April 16, 2024 | Client News, NASDAQ: MIGI
New Board Chair Appointment Highlights Continued Company Transformation and Enhances Focus on U.S. Operations and Growth Opportunities MIDLAND, Pa., April 15, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ: MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announced that the Board of Directors of the Company has appointed Ryan Costello as the Chair […]
April 15, 2024 | Client News, NASDAQ: LGVN
MIAMI, April 15, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a Featured Research Oral Presentation to present the Company’s CLEAR MIND Phase 2a study results. CLEAR-MIND is a Phase 2a randomized clinical trial evaluating Lomecel-BTM in mild Alzheimer’s Disease. In addition to the clinical […]
April 15, 2024 | Client News, NASDAQ: LASE
Fourth quarter revenue grew by 673% Fourth quarter operating and net losses improved by 36% and 86%, respectively ORLANDO, FL / ACCESSWIRE / April 15, 2024 / Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global industrial developer of CleanTech Laser Systems for laser cleaning and other applications, today announced financial results for its fourth quarter and year ended […]
April 15, 2024 | Client News
FORT LAUDERDALE, FL, April 12, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, issued a statement today reaffirming its commitment to sustainable growth and long-term success despite a going concern opinion. This advisement does not represent any change or amendment to […]
April 15, 2024 | Client News
AUSTIN, April 12, 2024 /PRNewswire/ — Digital Brands Group, Inc. (“DBG”) (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands, will report financial results for the fourth quarter ended December 31, 2023 on Monday, April 15, 2023 at 4:30 p.m. ET. Management will host a conference call on Monday, April 15 at 5:00 p.m. ET to discuss the results. The live conference call can be accessed by […]
April 12, 2024 | Client News, NASDAQ: LGVN
MIAMI, April 11, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced the closing of its previously announced public offering of up to 2,234,043 shares […]
